Corteva, Inc. (CTVA) – What Are Brokerages Saying About This Stock?

Shares of Corteva, Inc. (NYSE:CTVA) have received a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and sixteen have issued a buy rating on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $56.91.

Several research firms recently commented on CTVA. Deutsche Bank reissued a “buy” rating and set a $101.00 target price on shares of Corteva in a research note on Monday, August 3rd. UBS Group lowered their price objective on shares of Corteva to $15.00 and set a “neutral” rating on the stock in a research report on Monday, October 12th. New Street Research set a $17.00 target price on shares of Corteva in a research note on Monday, October 5th. JPMorgan Chase & Co. raised shares of Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 target price on the stock in a research note on Tuesday, October 6th. Finally, Mizuho set a $16.00 target price on Corteva in a research report on Thursday.

Key Corteva News

Here’s some of the latest news about CTVA:

• Positive Sentiment: Corteva said new-product sales growth and operational execution helped cushion market headwinds. One report also showed adjusted Q3 EPS of $0.06, above the $0.02 consensus estimate, though coverage described the overall quarter as weak and results varied by measure. Corteva Q3 results and outlook
• Negative Sentiment: Corteva lowered its 2026 EPS guidance to $0.76–$0.80, below the roughly $1.07 analyst consensus. The company cited weaker-than-expected conditions in Brazil, where the CEO warned the slump could continue. Reuters report on Brazil weakness and forecast cut
• Negative Sentiment: Brazilian weakness, competitive pricing and lower volumes weighed on sales and earnings. Revenue was down 8.7% year over year, while pricing pressure in North and Latin America added to concerns about the company’s near-term performance. Zacks report on Q3 results

Corteva Price Performance

Shares of Corteva stock opened at $9.26 on Friday. Corteva has a 52 week low of $9.14 and a 52 week high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The stock has a market cap of $6.18 billion, a PE ratio of 3.20, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company’s 50-day moving average price is $38.81 and its two-hundred day moving average price is $69.88.

Corteva Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be paid a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $0.20 annualized dividend and a yield of 2.2%. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Hedge Funds Weigh In On Corteva

Institutional investors and hedge funds have recently bought and sold shares of the business. Parkside Financial Bank & Trust raised its stake in shares of Corteva by 3.2% during the 2nd quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock worth $316,000 after purchasing an additional 116 shares in the last quarter. HB Wealth Management LLC increased its stake in shares of Corteva by 0.5% during the 2nd quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock worth $2,018,000 after purchasing an additional 128 shares during the last quarter. Wilkerson Advisory Group LLC raised its holdings in shares of Corteva by 6.7% during the 1st quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock valued at $177,000 after purchasing an additional 133 shares in the last quarter. First Horizon Corp raised its holdings in shares of Corteva by 9.2% during the 1st quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after purchasing an additional 135 shares in the last quarter. Finally, Aviance Capital Partners LLC lifted its stake in shares of Corteva by 1.3% in the 1st quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock valued at $922,000 after purchasing an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.